Patents Assigned to Predicine, Inc.
  • Patent number: 11913063
    Abstract: Disclosed are systems and methods for simultaneous detection of DNA and RNA genetic alterations comprising gene splicing variants, mutations, indel, copy number changes, fusion and combination thereof, in a biofluid sample from the patient without physically separating RNA from DNA. The systems and methods are similarly applicable to the simultaneous detection of DNA and RNA genetic alterations in solid tissues comprising gene splicing variants, mutations, indel, copy number changes, fusion and combination thereof. The present method utilized a barcoding method for analysis. The streamlined methods improve the simplicity, quantification accuracy and detection sensitivity and specificity of non-invasive detections of biomarkers.
    Type: Grant
    Filed: October 8, 2021
    Date of Patent: February 27, 2024
    Assignee: PREDICINE, INC.
    Inventors: Xiaohong Wang, Pan Du, Shidong Jia
  • Patent number: 11702702
    Abstract: Disclosed are systems and methods for detecting genetic alterations comprising androgen receptor gene splice variants (AR-Vs), mutations, indel, copy number changes, fusion and combination thereof, in a biofluid sample from the patient. The systems and methods are similarly applicable to the detection of gene alterations comprising gene splicing variants, mutations, indel, copy number changes, fusion and combination thereof of other genes of interest. The streamlined methods improve the consistency and simplicity of non-invasive detections of biomarkers.
    Type: Grant
    Filed: April 16, 2017
    Date of Patent: July 18, 2023
    Assignee: Predicine, Inc.
    Inventors: Shidong Jia, Pan Du, Xiaohong Wang
  • Patent number: 11174503
    Abstract: Disclosed are systems and methods for simultaneous detection of DNA and RNA genetic alterations comprising gene splicing variants, mutations, indel, copy number changes, fusion and combination thereof, in a biofluid sample from the patient without physically separating RNA from DNA. The systems and methods are similarly applicable to the simultaneous detection of DNA and RNA genetic alterations in solid tissues comprising gene splicing variants, mutations, indel, copy number changes, fusion and combination thereof. The present method utilized a barcoding method for analysis. The streamlined methods improve the simplicity, quantification accuracy and detection sensitivity and specificity of non-invasive detections of biomarkers.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: November 16, 2021
    Assignee: Predicine, Inc.
    Inventors: Xiaohong Wang, Pan Du, Shidong Jia